BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 28839000)

  • 1. Radiosensitization
    Groselj B; Ruan JL; Scott H; Gorrill J; Nicholson J; Kelly J; Anbalagan S; Thompson J; Stratford MRL; Jevons SJ; Hammond EM; Scudamore CL; Kerr M; Kiltie AE
    Mol Cancer Ther; 2018 Feb; 17(2):381-392. PubMed ID: 28839000
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Histone Deacetylase Inhibitor Romidepsin Spares Normal Tissues While Acting as an Effective Radiosensitizer in Bladder TumorsĀ inĀ Vivo.
    Paillas S; Then CK; Kilgas S; Ruan JL; Thompson J; Elliott A; Smart S; Kiltie AE
    Int J Radiat Oncol Biol Phys; 2020 May; 107(1):212-221. PubMed ID: 31987970
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Radiosensitisation of bladder cancer cells by panobinostat is modulated by Ku80 expression.
    Groselj B; Kerr M; Kiltie AE
    Radiother Oncol; 2013 Sep; 108(3):429-33. PubMed ID: 23932191
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Radiosensitization by SAHA in experimental colorectal carcinoma models-in vivo effects and relevance of histone acetylation status.
    Folkvord S; Ree AH; Furre T; Halvorsen T; Flatmark K
    Int J Radiat Oncol Biol Phys; 2009 Jun; 74(2):546-52. PubMed ID: 19427556
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vivo monitoring of the anti-angiogenic therapeutic effect of the pan-deacetylase inhibitor panobinostat by small animal PET in a mouse model of gastrointestinal cancers.
    Maschauer S; Gahr S; Gandesiri M; Tripal P; Schneider-Stock R; Kuwert T; Ocker M; Prante O
    Nucl Med Biol; 2016 Jan; 43(1):27-34. PubMed ID: 26702784
    [TBL] [Abstract][Full Text] [Related]  

  • 6. E3 Ligase cIAP2 Mediates Downregulation of MRE11 and Radiosensitization in Response to HDAC Inhibition in Bladder Cancer.
    Nicholson J; Jevons SJ; Groselj B; Ellermann S; Konietzny R; Kerr M; Kessler BM; Kiltie AE
    Cancer Res; 2017 Jun; 77(11):3027-3039. PubMed ID: 28363998
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Radiosensitization by the histone deacetylase inhibitor vorinostat under hypoxia and with capecitabine in experimental colorectal carcinoma.
    Saelen MG; Ree AH; Kristian A; Fleten KG; Furre T; Hektoen HH; Flatmark K
    Radiat Oncol; 2012 Sep; 7():165. PubMed ID: 23017053
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Histone deacetylase inhibitor panobinostat induces antitumor activity in epithelioid sarcoma and rhabdoid tumor by growth factor receptor modulation.
    Harttrampf AC; da Costa MEM; Renoult A; Daudigeos-Dubus E; Geoerger B
    BMC Cancer; 2021 Jul; 21(1):833. PubMed ID: 34281526
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ultrasound-Mediated Gemcitabine Delivery Reduces the Normal-Tissue Toxicity of Chemoradiation Therapy in a Muscle-Invasive Bladder Cancer Model.
    Ruan JL; Browning RJ; Yildiz YO; Gray M; Bau L; Kamila S; Thompson J; Elliott A; Smart S; McHale AP; Callan JF; Vojnovic B; Stride E; Kiltie AE
    Int J Radiat Oncol Biol Phys; 2021 Apr; 109(5):1472-1482. PubMed ID: 33714528
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Selective inhibition of HDAC6 promotes bladder cancer radiosensitization and mitigates the radiation-induced CXCL1 signalling.
    Tsai YC; Wang TY; Hsu CL; Lin WC; Chen JY; Li JH; Pu YS; Cheng AL; Cheng JC; Su SF
    Br J Cancer; 2023 May; 128(9):1753-1764. PubMed ID: 36810912
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Isotype-Specific Inhibition of Histone Deacetylases: Identification of Optimal Targets for Radiosensitization.
    Kim JH; Moon SH; No M; Kim JJ; Choi EJ; Cho BJ; Kim JS; Kim IH; Kim IA
    Cancer Res Treat; 2016 Jul; 48(3):1130-40. PubMed ID: 26582395
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vivo efficacy of the histone deacetylase inhibitor suberoylanilide hydroxamic acid in combination with radiotherapy in a malignant rhabdoid tumor mouse model.
    Thiemann M; Oertel S; Ehemann V; Weichert W; Stenzinger A; Bischof M; Weber KJ; Perez RL; Haberkorn U; Kulozik AE; Debus J; Huber PE; Battmann C
    Radiat Oncol; 2012 Mar; 7():52. PubMed ID: 22458853
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chloroquine Enhances the Radiosensitivity of Bladder Cancer Cells by Inhibiting Autophagy and Activating Apoptosis.
    Wang F; Tang J; Li P; Si S; Yu H; Yang X; Tao J; Lv Q; Gu M; Yang H; Wang Z
    Cell Physiol Biochem; 2018; 45(1):54-66. PubMed ID: 29316551
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Panobinostat, a histone deacetylase inhibitor, rescues the angiogenic potential of endothelial colony-forming cells in moyamoya disease.
    Jangra A; Choi SA; Koh EJ; Moon YJ; Wang KC; Phi JH; Lee JY; Kim SK
    Childs Nerv Syst; 2019 May; 35(5):823-831. PubMed ID: 30815722
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeting histone deacetylase 4/ubiquitin-conjugating enzyme 9 impairs DNA repair for radiosensitization of hepatocellular carcinoma cells in mice.
    Tsai CL; Liu WL; Hsu FM; Yang PS; Yen RF; Tzen KY; Cheng AL; Chen PJ; Cheng JC
    Hepatology; 2018 Feb; 67(2):586-599. PubMed ID: 28646552
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nanoparticle formulations of histone deacetylase inhibitors for effective chemoradiotherapy in solid tumors.
    Wang EC; Min Y; Palm RC; Fiordalisi JJ; Wagner KT; Hyder N; Cox AD; Caster JM; Tian X; Wang AZ
    Biomaterials; 2015 May; 51():208-215. PubMed ID: 25771011
    [TBL] [Abstract][Full Text] [Related]  

  • 17. PI3K/mTOR inhibition markedly potentiates HDAC inhibitor activity in NHL cells through BIM- and MCL-1-dependent mechanisms in vitro and in vivo.
    Rahmani M; Aust MM; Benson EC; Wallace L; Friedberg J; Grant S
    Clin Cancer Res; 2014 Sep; 20(18):4849-60. PubMed ID: 25070836
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preclinical evaluation of 5-iodo-2-pyrimidinone-2'-deoxyribose as a prodrug for 5-iodo-2'-deoxyuridine-mediated radiosensitization in mouse and human tissues.
    Kinsella TJ; Kunugi KA; Vielhuber KA; Potter DM; Fitzsimmons ME; Collins JM
    Clin Cancer Res; 1998 Jan; 4(1):99-109. PubMed ID: 9516958
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of class IIa histone deacetylase activity by gallic acid, sulforaphane, TMP269, and panobinostat.
    Choi SY; Kee HJ; Jin L; Ryu Y; Sun S; Kim GR; Jeong MH
    Biomed Pharmacother; 2018 May; 101():145-154. PubMed ID: 29482060
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Histone deacetylase inhibition decreases proliferation and potentiates the effect of ionizing radiation in atypical teratoid/rhabdoid tumor cells.
    Knipstein JA; Birks DK; Donson AM; Alimova I; Foreman NK; Vibhakar R
    Neuro Oncol; 2012 Feb; 14(2):175-83. PubMed ID: 22156471
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.